Consistency of the initial cell acquisition procedure is critical to the standardization of CD34+ cell enumeration by flow cytometry: Results of a pairwise analysis of umbilical cord blood units and cryopreserved aliquots

Transfusion

Volumn 49, Issue 4, 2009, Pages 636-647

  Flores, Ana I ^b   McKenna, David H ^b   Montalbán, M Angeles ^b   De La Cruz, Javier ^b   Wagner, John E ^b   Bornstein, Rafael ^a  

^a HOSPITAL CENTRAL DE LA CRUZ ROJA   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN;

ARTICLE; BLAND ALTMAN PLOT; CD34 SELECTION; CELL ISOLATION; CELL TRANSPLANTATION; CRYOPRESERVATION; FLOW CYTOMETRY; FREEZING; HUMAN; STATISTICAL MODEL; THAWING; UMBILICAL CORD BLOOD;

ANTIGENS, CD34; BLOOD CELL COUNT; CELL SEPARATION; CELL SURVIVAL; CELLS, CULTURED; CORD BLOOD STEM CELL TRANSPLANTATION; CRYOPRESERVATION; FACTOR VIII; FETAL BLOOD; FIBRINOGEN; FLOW CYTOMETRY; HUMANS; LINEAR MODELS; MATCHED-PAIR ANALYSIS; REPRODUCIBILITY OF RESULTS;

EID: 62949182821     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2008.02035.x     Document Type: Article

References (54)

1. Eapen M, Rubinstein P, Zhang MJ, Stevens C, Kurtzberg J, Scaradavou A, Loberiza FR, Champlin RE, Klein JP, Horowitz MM, Wagner JE. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. Lancet 2007 369 : 1947 54.
2. Laughlin MJ, Eapen M, Rubinstein P, Wagner JE, Zhang MJ, Champlin RE, Stevens C, Barker JN, Gale RP, Lazarus HM, Marks DI, van Rood JJ, Scaradavou A, Horowitz MM. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med 2004 351 : 2265 75.
3. Rocha V, Labopin M, Sanz G, Arcese W, Schwerdtfeger R, Bosi A, Jacobsen N, Ruutu T, de Lima M, Finke J, Frassoni F, Gluckman E. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med 2004 351 : 2276 85.
4. Takahashi W, Iseki T, Ooi J, Tomonari A, Takasugi K, Shimohakamada Y, Yamada T, Uchimaru K, Tojo A, Shirafuji N, Kodo H, Tani K, Takahashi T, Yamaguchi T, Asano S. Single-institute comparative analysis of unrelated bone marrow transplantation and cord blood transplantation for adult patients with hematologic malignancies. Blood 2004 104 : 3813 20.
5. Wagner JE, Rosenthal J, Sweetman R, Shu XO, Davies SM, Ramsay NK, McGlave PB, Sender L, Cairo MS. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease. Blood 1996 88 : 795 802.
6. Kurtzberg J, Laughlin M, Graham ML, Smith C, Olson JF, Halperin EC, Ciocci G, Carrier C, Stevens CE, Rubinstein P. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med 1996 335 : 157 66.
7. Gluckman E, Rocha V, Boyer-Chammard A, Locatelli F, Arcese W, Pasquini R, Ortega J, Souillet G, Ferreira E, Laporte JP, Fernandez M, Chastang C. Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N Engl J Med 1997 337 : 373 81.
8. Rubinstein P, Carrier C, Scaradavou A, Kurtzberg J, Adamson J, Migliaccio AR, Berkowitz RL, Cabbad M, Dobrila NL, Taylor PE, Rosenfield RE, Stevens CE. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998 339 : 1565 77.
9. Locatelli F, Rocha V, Chastang C, Arcese W, Michel G, Abecasis M, Messina C, Ortega J, Badell-Serra I, Plouvier E, Souillet G, Jouet JP, Pasquini R, Ferreira E, Garnier F, Gluckman E. Factors associated with outcome after cord blood transplantation in children with acute leukemia. Eurocord-Cord Blood Transplant Group. Blood 1999 93 : 3662 71.
10. Rocha V, Cornish J, Sievers EL, Filipovich A, Locatelli F, Peters C, Remberger M, Michel G, Arcese W, Dallorso S, Tiedemann K, Busca A, Chan KW, Kato S, Ortega J, Vowels M, Zander A, Souillet G, Oakill A, Woolfrey A, Pay AL, Green A, Garnier F, Ionescu I, Wernet P, Sirchia G, Rubinstein P, Chevret S, Gluckman E. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood 2001 97 : 2962 71.
11. Barker JN, Davies SM, DeFor T, Ramsay NK, Weisdorf DJ, Wagner JE. Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis. Blood 2001 97 : 2957 61.
12. Gluckman E. Hematopoietic stem-cell transplants using umbilical-cord blood [editorial]. N Engl J Med 2001 344 : 1860 1.
13. Laughlin MJ, Barker J, Bambach B, Koc ON, Rizzieri DA, Wagner JE, Gerson SL, Lazarus HM, Cairo M, Stevens CE, Rubinstein P, Kurtzberg J. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med 2001 344 : 1815 22.
14. Sanz FG, Saavedra S, Planelles D, Senent L, Cervera J, Barragán E, Jiménez C, Larrea L, Martín G, Martínez J, Jarque I, Moscardó F, Plumé G, Andreu R, Regadera AI, García I, Mollá S, Solves P, de La Rubia J, Bolufer P, Benlloch L, Soler MA, Marty ML, Sanz MA. Standardized, unrelated donor cord blood transplantation in adults with hematologic malignancies. Blood 2001 98 : 2332 8.
15. Michel G, Rocha V, Chevret S, Arcese W, Chan KW, Filipovich A, Takahashi TA, Vowels M, Ortega J, Bordigoni P, Shaw PJ, Yaniv I, Machado A, Pimentel P, Fagioli F, Verdeguer A, Jouet JP, Diez B, Ferreira E, Pasquini R, Rosenthal J, Sievers E, Messina C, Iori AP, Garnier F, Ionescu I, Locatelli F, Gluckman E. Unrelated cord blood transplantation for childhood acute myeloid leukemia: a Eurocord Group analysis. Blood 2003 102 : 4290 7.
16. Ooi J, Iseki T, Takahashi S, Tomonari A, Takasugi K, Shimohakamada Y, Yamada T, Ishii K, Ohno N, Nagamura F, Uchimaru K, Tojo A, Asano S. Unrelated cord blood transplantation for adult patients with de novo acute myeloid leukemia. Blood 2004 103 : 489 91.
17. Rocha V, Gluckman E. Clinical use of umbilical cord blood hematopoietic stem cells. Biol Blood Marrow Transplant 2006 12 Suppl 1 : 34 41.
18. Barker J, Scaradavou A, Stevens CE, Rubinstein P. Analysis of 608 umbilical cord blood (UCB) transplants: hla-match is a critical determinant of transplant-related mortality (TRM) in the post-engraftment period even in the absence of acute graft-vs-host disease (aGVHD). Blood 2005 106 : 92a 93a.
19. Barker JN. Who should get cord blood transplants? Biol Blood Marrow Transplant 2007 13 Suppl 1 : 78 82.
20. Bender JG, To LB, Williams S, Schwartzberg LS. Defining a therapeutic dose of peripheral blood stem cells. J Hematother 1992 1 : 329 41.
21. Weaver CH, Hazelton B, Birch R, Palmer P, Allen C, Schwartzberg L, West W. An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood 1995 86 : 3961 9.
22. Mavroudis D, Read E, Cottler-fox M, Couriel D, Molldrem J, Carter C, Yu M, Dunbar C, Barrett J. CD34+ cell dose predicts survival, post-transplant morbidity, and rate of hematologic recovery after allogeneic marrow transplants for hematologic malignancies. Blood 1996 88 : 3223 9.
23. Bahceci E, Read EJ, Leitman S, Childs R, Dunbar C, Young NS, Barrett AJ. CD34+ cell dose predicts relapse and survival after T-cell-depleted HLA identical hematopoietic stem cell transplantation (HSCT) for hematologic malignancies. Br J Haematol 2000 108 : 408 14.
24. Bittencourt H, Rocha V, Chevret S, Socié G, Espérou H, Devergie A, Dal Cortivo L, Marolleau JP, Garnier F, Ribaud P, Gluckman E. Association of CD34 cell dose with hematopoietic recovery, infections, and other outcomes after HLA-identical sibling bone marrow transplantation. Blood 2002 99 : 2726 33.
25. Wagner JE, Barker JN, DeFor TE, Baker KS, Blazar BR, Eide C, Goldman A, Kersey J, Krivit W, MacMillan ML, Orchard PJ, Peters C, Weisdorf DJ, Ramsay NK, Davies SM. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 2002 100 : 1611 8.
26. Styczynski J, Cheung YK, Garvin J, Savage DG, Billote GB, Harrison L, Skerrett D, Wolownik K, Wischhover C, Hawks R, Bradley MB, Del Toro G, George D, Yamashiro D, van de Ven C, Cairo MS. Outcomes of unrelated cord blood transplantation in pediatric recipients. Bone Marrow Transplant 2004 34 : 129 36.
27. Wall D, Wagner J, Laughlin M, Ballen K, Staba S, Chan KW, McGaha O, Logan B, Klein J, Arora M. Higher cell dose and CD34+ content improves engraftment following unrelated donor cord blood transplantation (CBT): a report of the National Marrow Donor Program (NMDP) Cord Blood (CB) Experience. Blood 2004 104 : 279a.
28. Sanz G, Lorenzo I, Moscardo F, Planelles D, Larrea L, Senent L, Benlloch L, Sanz J, Montesions P, Puig N, Jimenez C, Martinez J, Martin G, Jarque I, De la Rubia J, Soler MA, Marty ML, Sanz MA. Outcome and prognostic factors after unrelated donor umbilical cord blood transplantation in adult patients with hematologic malignancies transplanted in early disease stages. Blood 2004 104 : 591a.
29. Terakura S, Azuma E, Murata M, Kumamoto T, Hirayama M, Atsuta Y, Kodera Y, Yazaki M, Naoe T, Kato K. Hematopoietic engraftment in recipients of unrelated donor umbilical cord blood is affected by the CD34+ and CD8+ cell doses. Biol Blood Marrow Transplant 2007 13 : 822 30.
30. Bornstein R, Flores AI, Montalbán MA, Del Rey MJ, De la Serna J, Gilsanz F. A modified cord blood collection method achieves sufficient cell levels for transplantation in most adult patients. Stem Cells 2005 23 : 324 34.
31. Sutherland DR, Anderson L, Keeney M, Nayar R, Chin-Yee I. The ISHAGE guidelines for CD34+ cell determination by flow cytometry. J Hematother 1996 5 : 213 26.
32. Gratama JW, Menéndez P, Kraan J, Orfao A. Loss of CD34(+) hematopoietic progenitor cells due to washing can be reduced by the use of fixative-free erythrocyte lysing reagents. J Immunol Methods 2000 239 : 13 23.
33. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986 1 : 307 10.
34. Kurtzberg J, Cairo MS, Fraser JK, Baxter-Lowe L, Cohen G, Carter SL, Kernan NA. Results of the Cord Blood Transplantation (COBLT) Study unrelated donor banking program. Transfusion 2005 45 : 842 55.
35. Rogers I, Sutherland DR, Holt D, Macpate F, Lains A, Hollowell S, Cruickshank B, Casper RF. Human UC-blood banking: impact of blood volume, cell separation and cryopreservation on leukocyte and CD34+ cell recovery. Cytotherapy 2001 3 : 269 76.
36. Alonso JM 3rd., Regan DM, Johnson CE, Oliver DA, Fegan R, Lasky LC, Wall DA. A simple and reliable procedure for cord blood banking, processing, and freezing: St Louis and Ohio Cord Blood Bank experiences. Cytotherapy 2001 3 : 429 33.
37. M-Reboredo N, Díaz A, Castro A, Villaescusa RG. Collection, processing and cryopreservation of umbilical cord blood for unrelated transplantation. Bone Marrow Transplant 2000 26 : 1263 70.
38. Moroff G, Eichler H, Brand A, Kekomäki R, Kurtz J, Letowska M, Pamphilon D, Read EJ, Porretti L, Lecchi L, Reems JA, Sacher R, Seetharaman S, Takahashi TA. Multiple-laboratory comparison of in vitro assays utilized to characterize hematopoietic cells in cord blood. Transfusion 2006 46 : 507 15.
39. Mascotti K, McCullough J, Burger SR. HPC viability measurement: trypan blue versus acridine orange and propidium iodide. Transfusion 2000 40 : 693 6.
40. Burger SR, Kadidlo D, McCullough J. Improved progenitor assay standardization using peripheral blood progenitor cells from a donor treated with granulocyte-colony-stimulating factor. Transfusion 1999 39 : 451 6.
41. Bank HL. Assessment of islet cell viability using fluorescent dyes. Diabetologia 1987 30 : 812 6.
42. Jahanmehr SA, Hyde K, Geary CG, Cinkotai KI, Maciver JE. Simple technique for fluorescence staining of blood cells with acridine orange. J Clin Pathol 1987 40 : 926 9.
43. Keeney M, Chin-Yee I, Weir K, Popma J, Nayar R, Sutherland DR. Single platform flow cytometric absolute CD34+ cell counts based on the ISHAGE guidelines. Cytometry 1998 34 : 61 70.
44. Brocklebank AM, Sparrow RL. Enumeration of CD34+ cells in cord blood: a variation on a single-platform flow cytometric method based on the ISHAGE gating strategy. Cytometry 2001 46 : 254 61.
45. Brand A, Eichler H, Szczepiorkowski ZM, Hess JR, Kekomaki R, McKenna DH, Pamphilon D, Reems J, Sacher RA, Takahashi TA, van de Watering LM. Viability does not necessarily reflect the hematopoietic progenitor cell potency of a cord blood unit: results of an interlaboratory exercise. Transfusion 2008 48 : 546 9.
46. Cairo MS, Wagner EL, Fraser J, Cohen G, van de Ven C, Carter SL, Kernan NA, Kurtzberg J. Characterization of banked umbilical cord blood hematopoietic progenitor cells and lymphocyte subsets and correlation with ethnicity, birth weight, sex, and type of delivery: a Cord Blood Transplantation (COBLT) Study report. Transfusion 2005 45 : 856 66.
47. Solves P, Mirabet V, Carbonell-Uberos F, Soler A. CD34+ cell content before freezing represents the hematopoietic stem cell content of thawed and washed cord blood units. Transfusion 2005 45 : 116 7.
48. Wagner E, Duval M, Dalle JH, Morin H, Bizier S, Champagne J, Champagne MA. Assessment of cord blood unit characteristics on the day of transplant: comparison with data issued by cord blood banks. Transfusion 2006 46 : 1190 8.
49. Barnett D, Granger V, Whitby L, Storie I, Reilly JT. Absolute CD4+ T-lymphocyte and CD34+ stem cell counts by single-platform flow cytometry: the way forward. Br J Haematol 1999 106 : 1059 62.
50. Barnett D, Granger V, Kraan J, Whitby L, Reilly JT, Papa S, Gratama JW. Reduction of intra- and interlaboratory variation in CD34+ stem cell enumeration using stable test material, standard protocols and targeted training. Br J Haematol 2000 108 : 784 92.
51. Larghero J, Rea D, Brossard Y, Van Nifterik J, Delasse V, Robert I, Biscay N, Chantre E, Raffoux E, Socié G, Gluckman E, Benbunan M, Marolleau JP. Prospective flow cytometric evaluation of nucleated red blood cells in cord blood units and relationship with nucleated and CD34+ cell quantification. Transfusion 2006 46 : 403 6.
52. Laroche V, McKenna DH, Moroff G, Schierman T, Kadidlo D, McCullough J. Cell loss and recovery in umbilical cord blood processing: a comparison of postthaw and postwash samples. Transfusion 2005 45 : 1909 16.
53. Van haute I, Lootens N, De Smet S, De Buck C, Verdegem L, Vanheusden K, Pinxteren J, Vandekerckhove B. Viable CD34+ stem cell content of a cord blood graft: which measurement performed before transplantation is most representative? Transfusion 2004 44 : 547 54.
54. Porretti L, Puglisi G, De Bernardi N, Rebulla P, Scalamogna M, Sirchia G. Enumeration of CD34+ cells in fresh and thawed/washed placental/umbilical cord blood units and thawed unit segments. Haematologica 1999 84 : 561 2.